Md Sass Investors Services Raised By $367,200 Its Teva Pharmaceutical Inds LTD (TEVA) Holding; Last Week Lam Research (LRCX) Coverage

August 9, 2017 - By Nellie Frank

Among 18 analysts covering Lam Research Corporation (NASDAQ:LRCX), 15 have Buy rating, 0 Sell and 3 Hold. Therefore 83% are positive. Lam Research Corporation had 49 analyst reports since September 17, 2015 according to SRatingsIntel. On Tuesday, October 25 the stock rating was reinitiated by Goldman Sachs with “Neutral”. The rating was maintained by B. Riley & Co with “Buy” on Thursday, July 27. The stock has “Buy” rating by B. Riley & Co on Thursday, October 20. RBC Capital Markets downgraded the stock to “Underperform” rating in Monday, October 5 report. The firm has “Outperform” rating by Cowen & Co given on Thursday, December 10. Stifel Nicolaus maintained Lam Research Corporation (NASDAQ:LRCX) on Monday, November 21 with “Buy” rating. The stock has “Buy” rating by Cowen & Co on Thursday, July 27. The rating was maintained by RBC Capital Markets with “Underperform” on Thursday, October 22. Morgan Stanley maintained Lam Research Corporation (NASDAQ:LRCX) on Friday, July 7 with “Buy” rating. The stock has “Outperform” rating by Cowen & Co on Wednesday, October 21. See Lam Research Corporation (NASDAQ:LRCX) latest ratings:

03/08/2017 Broker: Citigroup Old Rating: Buy New Rating: Neutral Downgrade
27/07/2017 Broker: Berenberg Rating: Buy New Target: $200.0000
27/07/2017 Broker: RBC Capital Markets Rating: Buy New Target: $185.0000 Maintain
27/07/2017 Broker: Credit Suisse Rating: Buy New Target: $214.0000
27/07/2017 Broker: B. Riley & Co Rating: Buy New Target: $220.0000 Maintain
27/07/2017 Broker: Needham Rating: Buy New Target: $200.0000 Maintain
27/07/2017 Broker: KeyBanc Capital Markets Rating: Buy New Target: $202.0000
27/07/2017 Broker: Cowen & Co Rating: Buy New Target: $185.0000 Maintain
07/07/2017 Broker: Morgan Stanley Rating: Buy New Target: $168.0000 Maintain
16/06/2017 Broker: Needham Rating: Buy New Target: $175.0000 Maintain

Md Sass Investors Services Inc increased Teva Pharmaceutical Inds Ltd (TEVA) stake by 18.68% reported in 2016Q4 SEC filing. Md Sass Investors Services Inc acquired 10,200 shares as Teva Pharmaceutical Inds Ltd (TEVA)’s stock declined 15.11%. The Md Sass Investors Services Inc holds 64,800 shares with $2.35M value, up from 54,600 last quarter. Teva Pharmaceutical Inds Ltd now has $17.86 billion valuation. The stock rose 0.23% or $0.04 reaching $17.54 per share. About 60.04 million shares traded or 255.48% up from the average. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since August 9, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Among 27 analysts covering Teva Pharma (NYSE:TEVA), 7 have Buy rating, 2 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 82 analyst reports since July 21, 2015 according to SRatingsIntel. Morgan Stanley reinitiated Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Wednesday, July 29 with “Overweight” rating. The firm has “Outperform” rating by Oppenheimer given on Wednesday, December 7. The firm has “Hold” rating by Piper Jaffray given on Friday, July 14. Mizuho downgraded the stock to “Neutral” rating in Friday, February 10 report. The firm has “Hold” rating given on Thursday, June 22 by Cantor Fitzgerald. Maxim Group maintained the stock with “Hold” rating in Monday, February 13 report. The firm earned “Buy” rating on Tuesday, June 27 by Oppenheimer. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has “Neutral” rating given on Wednesday, November 16 by BTIG Research. Mizuho maintained Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on Tuesday, May 10 with “Buy” rating. The firm earned “Positive” rating on Thursday, September 29 by OTR Global.

Md Sass Investors Services Inc decreased Arris Intl Inc stake by 478,055 shares to 1.88 million valued at $56.78 million in 2016Q4. It also reduced Eqt Corp (NYSE:EQT) stake by 199,145 shares and now owns 703,101 shares. Eqt Midstream Partners Lp (NYSE:EQM) was reduced too.

Lam Research Corporation is a supplier of wafer fabrication equipment and services to the semiconductor industry. The company has market cap of $25.04 billion. The Firm designs, makes, markets, refurbishes and services semiconductor processing systems that are used in the fabrication of integrated circuits . It has a 16.86 P/E ratio. It operates through manufacturing and servicing of wafer processing semiconductor manufacturing equipment segment.

Since February 10, 2017, it had 0 buys, and 17 insider sales for $34.25 million activity. Another trade for 2,770 shares valued at $430,320 was made by LORD PATRICK J on Tuesday, June 13. O’Dowd Sarah A had sold 6,459 shares worth $759,976 on Monday, March 6. ARCHER TIMOTHY had sold 30,000 shares worth $3.53 million on Friday, February 17. NEWBERRY STEPHEN G also sold $3.01M worth of Lam Research Corporation (NASDAQ:LRCX) on Thursday, May 18. Another trade for 3,741 shares valued at $429,841 was sold by Bettinger Douglas R. $5.80M worth of stock was sold by Anstice Martin B on Monday, March 13. Gottscho Richard A also sold $9.96 million worth of Lam Research Corporation (NASDAQ:LRCX) shares.